(Q36295098)

13 August 2017

Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions (English)

1 reference

13 August 2017

Salama G

1

1 reference

13 August 2017

Miédougé M

2

1 reference

13 August 2017

Rouzaud P

3

1 reference

13 August 2017

Mauduyt MA

4

1 reference

13 August 2017

Pujazon MC

5

1 reference

13 August 2017

Vincent C

6

1 reference

13 August 2017

Carles P

7

1 reference

13 August 2017

Serre G

8

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

British Journal of Cancer

13 August 2017

1 reference

13 August 2017

77

1 reference

13 August 2017

3

1 reference

13 August 2017

472-476

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1998.75

13 August 2017

0 references

cites work

Clinical significance of serum CYFRA 21-1 in gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151287

Thoracoscopy: present diagnostic and therapeutic indications.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151287

Continuing increase in mesothelioma mortality in Britain.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151287

The diagnostic and therapeutic utility of thoracoscopy. A review.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151287

Clinical evaluation of seven tumour markers in lung cancer diagnosis: can any combination improve the results?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151287

Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151287

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151287

The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151287

The malignant pleural effusion. A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151287

Diagnostic significance of carcinoembryonic antigen in the differential diagnosis of malignant mesothelioma.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151287

Immunophenotyping of Mesothelial Cells and Carcinoma Cells With Monoclonal Antibodies to Cytokeratins, Vimentin, Cea and Ema Improves the Cytodiagnosis of Serous Effusions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2151287

Clinical evaluation of soluble cytokeratin 19 fragments (CYFRA 21-1) in serum and urine of patients with bladder cancer

29 June 2018

1 reference

12 December 2020

Coexpression of simple epithelial keratins and vimentin by human mesothelium and mesothelioma in vivo and in culture

1 reference

12 December 2020

Tissue polypeptide antigen (TPA) in pleural effusions

1 reference

12 December 2020

Ca 72-4 radioimmunoassay in the diagnosis of malignant effusions. Comparison of various tumor markers

1 reference

12 December 2020

Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer

1 reference

12 December 2020

CYFRA 21-1. A new marker in lung cancer

1 reference

12 December 2020

Determination of serum levels of different cytokeratins in patients with uterine malignancies

1 reference

12 December 2020

Study of a new tumor marker, CYFRA 21-1, in malignant and nonmalignant diseases

1 reference

12 December 2020

Cyfra 21-1. A new potential tumor marker for squamous cell carcinoma of head and neck

1 reference

12 December 2020

[Diagnostic value of tissue polypeptide antigen in pleural effusions with malignant pleural mesothelioma]

1 reference

12 December 2020

Clinical evaluation of CYFRA 21-1 in malignant pleural fluids

1 reference

12 December 2020

Cytokeratin fragment 21-1 in gynecologic malignancy: comparison with cancer antigen 125 and squamous cell carcinoma-related antigen

1 reference

12 December 2020

Evaluation of CYFRA 21-1 in malignant and benign pleural effusions

1 reference

12 December 2020

Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients

1 reference

12 December 2020

CEA, CA 15-3 and CYFRA 21-1 in serum and pleural fluid of patients with pleural effusions

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1998.75

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

9472646

1 reference